These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
752 related articles for article (PubMed ID: 21778406)
1. Pathway and mechanism of drug binding to G-protein-coupled receptors. Dror RO; Pan AC; Arlow DH; Borhani DW; Maragakis P; Shan Y; Xu H; Shaw DE Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13118-23. PubMed ID: 21778406 [TBL] [Abstract][Full Text] [Related]
2. Structural features of β2 adrenergic receptor: crystal structures and beyond. Bang I; Choi HJ Mol Cells; 2015; 38(2):105-11. PubMed ID: 25537861 [TBL] [Abstract][Full Text] [Related]
3. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors. Emtage AL; Mistry SN; Fischer PM; Kellam B; Laughton CA J Biomol Struct Dyn; 2017 Sep; 35(12):2604-2619. PubMed ID: 27532213 [TBL] [Abstract][Full Text] [Related]
4. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery. Huber T; Menon S; Sakmar TP Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775 [TBL] [Abstract][Full Text] [Related]
5. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study. Kooistra AJ; Leurs R; de Esch IJ; de Graaf C J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966 [TBL] [Abstract][Full Text] [Related]
6. Activation mechanism of the β2-adrenergic receptor. Dror RO; Arlow DH; Maragakis P; Mildorf TJ; Pan AC; Xu H; Borhani DW; Shaw DE Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18684-9. PubMed ID: 22031696 [TBL] [Abstract][Full Text] [Related]
7. Ligand entry and exit pathways in the beta2-adrenergic receptor. Wang T; Duan Y J Mol Biol; 2009 Oct; 392(4):1102-15. PubMed ID: 19665031 [TBL] [Abstract][Full Text] [Related]
8. Comparison of dynamics of extracellular accesses to the β(1) and β(2) adrenoceptors binding sites uncovers the potential of kinetic basis of antagonist selectivity. Selvam B; Wereszczynski J; Tikhonova IG Chem Biol Drug Des; 2012 Aug; 80(2):215-26. PubMed ID: 22530954 [TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor. Goetz A; Lanig H; Gmeiner P; Clark T J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586 [TBL] [Abstract][Full Text] [Related]
10. An allosteric modulator binds to a conformational hub in the β Liu X; Kaindl J; Korczynska M; Stößel A; Dengler D; Stanek M; Hübner H; Clark MJ; Mahoney J; Matt RA; Xu X; Hirata K; Shoichet BK; Sunahara RK; Kobilka BK; Gmeiner P Nat Chem Biol; 2020 Jul; 16(7):749-755. PubMed ID: 32483378 [TBL] [Abstract][Full Text] [Related]
11. Influence of lipid composition on the structural stability of g-protein coupled receptor. Mahmood I; Liu X; Neya S; Hoshino T Chem Pharm Bull (Tokyo); 2013; 61(4):426-37. PubMed ID: 23546002 [TBL] [Abstract][Full Text] [Related]
12. Modeling the possible conformations of the extracellular loops in G-protein-coupled receptors. Nikiforovich GV; Taylor CM; Marshall GR; Baranski TJ Proteins; 2010 Feb; 78(2):271-85. PubMed ID: 19731375 [TBL] [Abstract][Full Text] [Related]
13. Cholesterol-β1 AR interaction versus cholesterol-β2 AR interaction. Cang X; Yang L; Yang J; Luo C; Zheng M; Yu K; Yang H; Jiang H Proteins; 2014 May; 82(5):760-70. PubMed ID: 24265091 [TBL] [Abstract][Full Text] [Related]
14. Cell signalling: Binding the receptor at both ends. Sprang SR Nature; 2011 Jan; 469(7329):172-3. PubMed ID: 21228868 [TBL] [Abstract][Full Text] [Related]
15. An Integrated Markov State Model and Path Metadynamics Approach To Characterize Drug Binding Processes. Bernetti M; Masetti M; Recanatini M; Amaro RE; Cavalli A J Chem Theory Comput; 2019 Oct; 15(10):5689-5702. PubMed ID: 31436987 [TBL] [Abstract][Full Text] [Related]